VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced that the U.S. Food and Drug ...

"Chronic Periodontitis Pipeline"The therapeutic pipeline for chronic periodontitis is advancing, with growing interest in regenerative medicine, host-modulation, and novel antimicrobials. Current ...

Periodontal diseases comprise a wide range of inflammatory conditions that affect the supporting structures of the teeth (the gingiva, bone and periodontal ligament), which could lead to tooth loss ...

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System, a neuroimmune modulation therapy designed for patients with ...

High unmet need and current treatment landscape for pacemaker-indicated patients with uncontrolled hypertension; AVIM therapy mechanism of action and supporting clinical and non-clinical mechanistic ...

January 21, 2008 (London, UK)-A novel treatment that triggers a nonspecific immune response believed to attenuate inflammatory processes associated with heart failure failed to improve survival or ...

Mississauga, ON - Vasogen has reported that its phase 3 trial of its immune-modulation therapy, Celacade, in advanced chronic heart failure has failed to meet its primary end point of a reduction in ...

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...

This is a preview. Log in through your library . Abstract Infection with Plasmodium berghei ANKA is a well-established model of human cerebral malaria (CM). We show herein that Toll-like receptor (TLR ...